An AI-driven review of oncology trials reveals that diversity progress over 30 years is largely an illusion driven by Asian enrollment growth.
Rahman Olusoji, MBBS
Advertisement
Articles by Rahman Olusoji, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Sudden Death in HFpEF Often Preceded by Clinical Decline
3
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
4
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
5